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Table 2. Echocardiographic and blood pressure parameters of the patients
Group 1 Group 2 Group 3 p value
Aortic
diastolic
diameter
(cm)
3,29 (2,8-3,9) 3,38 (2,8-4,2) 3,42 (2,6-4,7) 0,585
P
O
S
T
E
R
Salso correlated with DM duration (r¼-0,172; p: 0,05) and age (r¼-0,27; p:0,006).
Signiﬁcant correlation was determined between aortic strain and fasting blood
glucose, HbA1c level and DM duration (respectively r¼-0,265; p:0,008, r¼0,279;
p:0,005 ve r¼-0,14; p:0,03) (Table 3 and Figure 2).
Conclusıon: In this study, we showed that aortic stiffness was increased in newly
diagnosis diabetes mellitus. Echocardiographically noninvasive evaluation of aortic
stiffness may be helpful in estimation of cardiovascular risk in patients with diabetes
mellitus.Table 1. Clinical and laboratory ﬁndings of the patients
I
n: 15
Median
(Min-Max)
II
n: 31
Median
(Min-Max)
III
n: 54
Median
(Min-Max) p value
Age
(year)
52.8
(39-72)
57,8
(45-72)
58,4
(39-80)
0,217
HT
duration
(year)
2,4 (0-10) 4,5 (0-20) 5,1 (0-20) 0,188
DM
duration
(year)
3,9 (1-7) 5,6 (1-30) 8,0 (1-20) 0,009
T.chol
(mg/dl)
181,6
(114-236)
191,8
(111-297)
193,6
(115-280)
0,558
LDL
(mg/dl)
104,0
(62-176)
115,5
(47-191)
115,4
(55-183)
0,409
HDL
(mg/dl)
47,6
(28-101)
45,6
(30-74)
40,5
(24-62)
0,174
Triglyseride
(mg/dl)
150,0
(75-266)
157,7
(68-324)
194,0
(56-8639)
0,305
HsCRP 2,27 (0-6) 2,14 (0-11) 12,8 (0-529) 0,343
BMI
(kg/m2)
26,8
(23-35,5)
30,3
(28,2-39,4)
30,78
(28,8-38,6)
0,365
FBG
(mg/dl)
117,5
(89-155)
135,5
(94-223)
209,9
(101-412)
<0,001
HT: hypertension, DM: diabetes mellitus, T.chol: total cholesterol, LDL: low density lipoprotein,
HDL: high density liporotein, hsCRP: high sensitive C reactive protein, BMI: body mass index,
FBG: fasting blood glucose.
Aortic
systolic
diameter
(cm)
3,56 (3,0-4,5) 3,59 (3,0-4,5) 3,58 (2,7-4,8) 0,918
Aortic
systolic-
diastolic
diameter(cm)
0,27
(0,11-0,60)
0,21
(0,04-0,62)
0,15
(0,06-0,40)
0,001
Systolic
blood
pressure
(mmhg)
133 (92-190) 129 (100-156) 132 (95-188) 0,759
Diastolic
blood
pressure
(mmhg)
80 (60-110) 79 (50-113) 79 (43-103) 0,898
Pulse
pressure
(mmhg)
54 (24-90) 49 (26-75) 53 (25-88) 0,558
Aortic
distensibility
(cm2/dyn/103)
2,48
(0,92-5,74)
1,93 (0,39-4,1) 1,45 (0,334,26) 0,002
aortic
strain (%)
7,48
(2,69-13,3)
6,0
(1,33-16,6)
4,54 (1,4-11,0) 0,001
Table 3. The relation between aortic stiffness parameters and demographic
characteristics of the patients
Aortic distensibility Aortic strain
r value p value r value p value
Age (year) 0.183 0.69
DM duration (year) -0,172 0,05 -0.148 0.03
HT duration (year) 0,51 0.613 0.47 0.645
FBG (mg/dl) -0,292 0.003 -0.265 0.008
Total cholesterol (mg/dl) 0.30 0.768 0.27 0.79
LDL (mg/dl) 0.54 0.591 0.21 0.834
HDL (mg/dl) 0.142 0.16 0.115 0.253
Triglyceride (mg/dl) -0.123 0.224 -0.104 0.301
BMI (kg/m2) 0.30 0.77 0.09 0.32
hsCRP -0.150 0.136 -0.163 0.106
HbA1c 0.283 0.004 0.279 0.005
DM: diabetes mellitus, T: hypertension, LDL: low density lipoprotein, HDL: high density lip-
orotein, hsCRP: high sensitive C reactive protein, BMI: body mass index, FBG: fasting blood
glucose.
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Introductıon: It is well known that diabetes leads to impairment of atrial fuctions.
Nevertheless, impaired atrial function is an independent predictor of atrial ﬁbrillation.
Although there are several studies demonstrating impaired atrial functions in diabetic
patients, data regarding pre-diabetic (Pre-DM) patients are scarce. The aim of this
study was to evaluate atrial functions including mechanical and tissue doppler
parameters in pre-diabetic patients.
Methods: We enrolled 80 patients diagnosed with pre-diabetes and 40 controls with
normal glucose levels. Pre-diabetes was diagnosed according to American Diabetes
Association (ADA-2013) guidelines. According to the ADA guidelines 27 of our
patients were isolated in the impaired fasting glucose group (i-IFG) pre-dm and 53l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
Table
Variables
Control
(n¼40)
Pre-DM
(n¼80) P values
IAS Va(cm/s) 8.142.2 8.592.1 0.29
LA Va(cm/s) 8.972.1 9.62 2.0 0.11
RA Va (cm/s) 11.072.2 11.282.2 0.64
IAS To (ms) 28.57.3 34.210.7 0.003
IAS Tp (ms) 82.9515.2 86.7820.9 0.26
IAS Te (ms) 123.113.3 134.723.7 0.001
LA To (ms) 29.588.8 36.1110.23 0.001
LA Tp (ms) 88.8516.5 96.7524.4 0.07
LA Te (ms) 124.8516.2 139.8124.6 p<0.001
RA To (ms) 28.407.6 32.689.8 0.01
RA Tp (ms) 88.0314.6 92.9626.2 0.20
RA Te (ms) 130.5014.0 145.429.4 p<0.001
Passive emptying fraction(%) 19.27.9 25.97.5 p<0.001
Diastolic emptying fraction(%) 43.613 34.45.9 0.001were in the combined group (fasting plasma glucose levels of 100 mg/dl to 125 mg/dl
and oral glucose tolerance test values of 140 mg/dl to 199 mg/dl) pre-dm (Totally 80
pre-dm patients). Atrial tissue doppler parameters were measured with transthoracic
echocardiography. Both left and right atrial measurements were performed at peak
regional atrial contraction velocity (Va), which reﬂects atrial systolic functions, atrial
mechanical times (The time between the onset of P wave on the surface ECG to the
onset to peak Tp, the end of the atrial contraction (Te), and atrial mechanical functions
(derived from atrial volumes, which are indexed to body surface area) were compared
between groups (ﬁgures 1, 2).
Results: The main demographic characteristics were comparable between groups.
There was no signiﬁcant difference between control and i-IFG group pre-dm in all
atrial parameters. Also there was no signiﬁcant difference between groups in terms of
Va (Table). But To and Te values were signiﬁcantly higher in pre-dm patients
compared with control group (Table). These differences were clearly seen between the
control group and the combined group pre-dm subjects. Of the atrial mechanical
functions, passive empting fraction and diastolic emptying fraction were signiﬁcantly
decreased in pre-dm patients (especially in combined group pre-dm) compared with
controls (19.27.9 vs. 25.97.5 mL/m2, p<0.001 and 43.613.8 vs 34.45.9 ml/m2,
p¼0.001, respectively) (Table).
Conclusıons: Atrial functions are impaired in the pre-diabetic period before devel-
opment of overt diabetes. This condition is an evidence of that chronic hyperglycemia
may contribute to atrial re-modeling with numerous mechanisms before development
of diabetes mellitus.Active emptying fraction (%) 22.87.6 27.213.7 0.09
Comparison of atrial functions. Pre-DM,prediabetes; IAS,inter-atrial septum; LA-left atrium;
RA-right atrium; Va-regional atrial contraction peak velocity; The time between the onset of P
wave on the surface ECG to the onset To, to peak Tp, and end of the atrial contraction Te.
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The relationship between epicardial fat tissue (EFT) and left ventricular (LV)
dysfunction, cardiovascular metabolism, and coronary artery disease is well known.
The objective of this study was to evaluate EFT in patients with chronic obstructive
pulmonary disease (COPD) who also have right ventricular systolic dysfunction
(RVSD).
This observational study was comprised of 98 patients with COPD and 40 healthy
controls, who were divided into groups according to fractional area changes (FACs) in
order to evaluate right ventricular functions. Subgroup analysis was performed
according to degree of RVSD in the patients with COPD (RVFAC<17%, 25-31%, or
32-60%). Statistical analysis was performed using Student's t-test, the Mann-Whitney
U test, and a chi-square test along with the Kruskal-Wallis one-way analysis of
variance (ANOVA) and one-way ANOVA post-hoc tests.
The EFT decreased in the patients with COPD compared with the control group
(4.921.2 versus 6.351.1, respectively; p¼0.001), and the mean EFT was 4.10.77
mm in patients with severe RVSD and 5.481.28 mm in patients with mild RVSD (p
<0.001). The difference among the three groups was independent of body mass index
(BMI).
Our data points to the fact that the EFT decreases in patients with COPD who have
RVSD and that it is also a predictor for the degree of RVSD.ERS C169
